SCHEMBL4015250

SCHEMBL4015250

CN1CCN(c2ccc(-c3cc[nH]n3)c(-c3ccc(N)cc3)c2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA2C P18825 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ GAA P10253 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ PTK2B Q14289 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ GFER P55789 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ ESR2 Q92731 1/20 0.49
▸ JAK2 O60674 1/20 0.44
▸ HRH4 Q9H3N8 1/20 0.43
▸ FYN P06241 4/20 0.41
▸ AURKA O14965 1/20 0.41
▸ MELK Q14680 1/20 0.41
▸ RPS6KA3 P51812 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ ADORA2A P29274 2/20 0.40
▸ ADORA1 P30542 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27649623 0.88 ADRA2C (0.50) ADRA2CKDM4EGAAMAPTPTK2B
SCHEMBL28470068 0.87 ALK (0.51) KDM4EMAPTALDH1A1HRH4FYN
SCHEMBL27649461 0.87 KDM4E (0.48) KDM4EGAAMAPTALDH1A1KMT2A
SCHEMBL27669767 0.84 ADRA2C (0.50) ADRA2CKDM4EGAAMAPTPTK2B
SCHEMBL27649645 0.82 AURKA (0.43) ADRA2CKDM4EGAAMAPTPTK2B
SCHEMBL27669648 0.81 HTR6 (0.44) KDM4EGAAALDH1A1GFERJAK2
SCHEMBL27669721 0.77 MAP4K1 (0.49) KDM4EALDH1A1KMT2AJAK2MAP4K1
SCHEMBL27649425 0.75 ALDH1A1 (0.54) KDM4EMAPTALDH1A1JAK2MAPK1
SCHEMBL27649830 0.72 HTR6 (0.45) ADRA2CHRH4MELK
SCHEMBL2385795 0.71 HRH4 (0.64) ADRA2CKDM4EGAAMAPTPTK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074127-A1 PYRAZOLO [1, 5-A]PYRIMIDINE DERIVATIVES AND THEIR THERAPEUTIC USE Novartis AG (CH) 2009-07-01 — — EP disclosed
WO-2008037459-A1 PYRAZOLO [1, 5-A] PYRIMIDINE DERIVATIVES AND THEIR THERAPEUTIC USE NOVARTIS AG (CH) 2008-04-03 — — WO disclosed
Send feedback